Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial
Gespeichert in:
Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.6627-6628 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6628 |
---|---|
container_issue | Supplement 1 |
container_start_page | 6627 |
container_title | Blood |
container_volume | 140 |
creator | Liu, Yizhen Zhang, Qunling Lv, Fangfang Liu, Xiaojian Ji, Dongmei Xia, Zuguang Jin, Jia TAO, Rong Zhang, Wenhao Li, Xiaoqiu Zhang, Shengjian Wang, Jiachen Hong, Xiaonan Cao, Junning |
description | |
doi_str_mv | 10.1182/blood-2022-158657 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_158657</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122045049</els_id><sourcerecordid>S0006497122045049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c947-bdfce52010216e8752c6f549c86c51c93e5cabb7f34ba0077bfee605198c17403</originalsourceid><addsrcrecordid>eNp9kM1u2zAQhIkiBeqkfYDeeGwOTJa0qJ_2lChJY0BoDMN3gaKW8RaUaJC2Ez9S37JK3HNPc9iZwezH2FcJV1KW6rrzIfRCgVJC6jLXxQc2k1qVAkDBGZsBQC6yqpCf2HlKvwFkNld6xv4sI3oaaDTxyFeY9n7Hg-MNjsZTHwbqkddh6GjEnr_QbsNXon58Wn5bqXe95DTyX_jij_yOzPMY0uS7C_vOo7h_3UZMKcTp5Nw-IW9MfEZ-K2r0njfHYbsJg_nOb_gyhrRFu6MD8uXGTNbFgteeRrLG83Uk4z-zj874hF_-6QVbP9yv60fRPP1c1DeNsFVWiK53FrUCCUrmWBZa2dzprLJlbrW01Ry1NV1XuHnWGYCi6BxiDlpWpZVFBvMLJk-1dpqUIrp2G2mY6LQS2jfU7Tvq9g11e0I9ZX6cMjjtOhDGNlnC0WJPcXqq7QP9J_0XPG-HYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Liu, Yizhen ; Zhang, Qunling ; Lv, Fangfang ; Liu, Xiaojian ; Ji, Dongmei ; Xia, Zuguang ; Jin, Jia ; TAO, Rong ; Zhang, Wenhao ; Li, Xiaoqiu ; Zhang, Shengjian ; Wang, Jiachen ; Hong, Xiaonan ; Cao, Junning</creator><creatorcontrib>Liu, Yizhen ; Zhang, Qunling ; Lv, Fangfang ; Liu, Xiaojian ; Ji, Dongmei ; Xia, Zuguang ; Jin, Jia ; TAO, Rong ; Zhang, Wenhao ; Li, Xiaoqiu ; Zhang, Shengjian ; Wang, Jiachen ; Hong, Xiaonan ; Cao, Junning</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-158657</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.6627-6628</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids></links><search><creatorcontrib>Liu, Yizhen</creatorcontrib><creatorcontrib>Zhang, Qunling</creatorcontrib><creatorcontrib>Lv, Fangfang</creatorcontrib><creatorcontrib>Liu, Xiaojian</creatorcontrib><creatorcontrib>Ji, Dongmei</creatorcontrib><creatorcontrib>Xia, Zuguang</creatorcontrib><creatorcontrib>Jin, Jia</creatorcontrib><creatorcontrib>TAO, Rong</creatorcontrib><creatorcontrib>Zhang, Wenhao</creatorcontrib><creatorcontrib>Li, Xiaoqiu</creatorcontrib><creatorcontrib>Zhang, Shengjian</creatorcontrib><creatorcontrib>Wang, Jiachen</creatorcontrib><creatorcontrib>Hong, Xiaonan</creatorcontrib><creatorcontrib>Cao, Junning</creatorcontrib><title>Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u2zAQhIkiBeqkfYDeeGwOTJa0qJ_2lChJY0BoDMN3gaKW8RaUaJC2Ez9S37JK3HNPc9iZwezH2FcJV1KW6rrzIfRCgVJC6jLXxQc2k1qVAkDBGZsBQC6yqpCf2HlKvwFkNld6xv4sI3oaaDTxyFeY9n7Hg-MNjsZTHwbqkddh6GjEnr_QbsNXon58Wn5bqXe95DTyX_jij_yOzPMY0uS7C_vOo7h_3UZMKcTp5Nw-IW9MfEZ-K2r0njfHYbsJg_nOb_gyhrRFu6MD8uXGTNbFgteeRrLG83Uk4z-zj874hF_-6QVbP9yv60fRPP1c1DeNsFVWiK53FrUCCUrmWBZa2dzprLJlbrW01Ry1NV1XuHnWGYCi6BxiDlpWpZVFBvMLJk-1dpqUIrp2G2mY6LQS2jfU7Tvq9g11e0I9ZX6cMjjtOhDGNlnC0WJPcXqq7QP9J_0XPG-HYQ</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Liu, Yizhen</creator><creator>Zhang, Qunling</creator><creator>Lv, Fangfang</creator><creator>Liu, Xiaojian</creator><creator>Ji, Dongmei</creator><creator>Xia, Zuguang</creator><creator>Jin, Jia</creator><creator>TAO, Rong</creator><creator>Zhang, Wenhao</creator><creator>Li, Xiaoqiu</creator><creator>Zhang, Shengjian</creator><creator>Wang, Jiachen</creator><creator>Hong, Xiaonan</creator><creator>Cao, Junning</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial</title><author>Liu, Yizhen ; Zhang, Qunling ; Lv, Fangfang ; Liu, Xiaojian ; Ji, Dongmei ; Xia, Zuguang ; Jin, Jia ; TAO, Rong ; Zhang, Wenhao ; Li, Xiaoqiu ; Zhang, Shengjian ; Wang, Jiachen ; Hong, Xiaonan ; Cao, Junning</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c947-bdfce52010216e8752c6f549c86c51c93e5cabb7f34ba0077bfee605198c17403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yizhen</creatorcontrib><creatorcontrib>Zhang, Qunling</creatorcontrib><creatorcontrib>Lv, Fangfang</creatorcontrib><creatorcontrib>Liu, Xiaojian</creatorcontrib><creatorcontrib>Ji, Dongmei</creatorcontrib><creatorcontrib>Xia, Zuguang</creatorcontrib><creatorcontrib>Jin, Jia</creatorcontrib><creatorcontrib>TAO, Rong</creatorcontrib><creatorcontrib>Zhang, Wenhao</creatorcontrib><creatorcontrib>Li, Xiaoqiu</creatorcontrib><creatorcontrib>Zhang, Shengjian</creatorcontrib><creatorcontrib>Wang, Jiachen</creatorcontrib><creatorcontrib>Hong, Xiaonan</creatorcontrib><creatorcontrib>Cao, Junning</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yizhen</au><au>Zhang, Qunling</au><au>Lv, Fangfang</au><au>Liu, Xiaojian</au><au>Ji, Dongmei</au><au>Xia, Zuguang</au><au>Jin, Jia</au><au>TAO, Rong</au><au>Zhang, Wenhao</au><au>Li, Xiaoqiu</au><au>Zhang, Shengjian</au><au>Wang, Jiachen</au><au>Hong, Xiaonan</au><au>Cao, Junning</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>6627</spage><epage>6628</epage><pages>6627-6628</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-158657</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.6627-6628 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_crossref_primary_10_1182_blood_2022_158657 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
title | Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T08%3A06%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20Result%20of%20Lenalidomide%20Combined%20with%20R-CHOP(R2-CHOP)%20in%20Newly%20Diagnosed%20Double-Expressor%20Diffuse%20Large%20B-Cell%20Lymphoma:%20A%20Prospective%20Phase%20II%20Clinical%20Trial&rft.jtitle=Blood&rft.au=Liu,%20Yizhen&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=6627&rft.epage=6628&rft.pages=6627-6628&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-158657&rft_dat=%3Celsevier_cross%3ES0006497122045049%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122045049&rfr_iscdi=true |